NASDAQ:MBX | Free Cash Flow | MBX Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$20.21M$437,000.00-$20.65M
2025-12-31-$18.3M$793,000.00-$19.09M
2025-03-31-$22.68M$30,000.00-$22.71M
2024-12-31-$16.04M$92,000.00-$16.13M
2024-03-31-$10.71M$273,000.00-$10.98M
2023-12-31-$11.15M$55,000.00-$11.2M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$79.95M$1.93M-$81.88M
2024-12-31-$54.68M$874,000.00-$55.56M
2023-12-31-$31.98M$129,000.00-$32.11M